WTAP and osteosarcoma: For instance, WTAP, which is highly expressed in osteosarcoma tissues and associated with the worse prognosis of osteosarcoma patients, was found to potentially promote osteosarcoma progression by inhibiting HMBOX1 in an m6A-dependent manner in vitro and in vivo (Chen et al., 2020).